Diabetic patients at no or low risk can be managed by education and self-care
The pharmaceutical segment dominates the market by holding 45.3% of revenue share in 2024 and is expected to expand at more than 6.8% CAGR between 2025 and 2034, with an estimated target valuation exceeding USD 221.5 million by 2034
Hin ti vin ngm Glutathione c mt nhiu quc gia trn th gii nh : Italy, Singapore, Hn Quc, Nht Bn, Thailand, Trung Quc, Philippines, Azerbaijan v ti Vit Nam
Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review
J Biomater Appl
(Patients already with kidney disease, 100x dosages of creatine, etc)